Table 1 |
|||||
|
Baseline study characteristics (n = 3522, aged 18–97 years). |
|||||
| Variables |
HbA1C < 7% n = 835(%) |
HbA1C ≥ 7 n = 2688 (%) |
Total No (%) |
P value |
|
|
|
|||||
| Gender |
Men |
383 (22.8) |
1299 (77.2) |
1676(47.6) |
0.282 |
| Women |
442 (24.3) |
1374 (75.7) |
1816 (51.5) |
||
| Age |
55.14 ± 12.96 |
53.35 ± 12.73 |
53.78 ± 12.81 |
0.622 |
|
| Smoker |
141 (19.4) |
585 (80.6) |
726(20.6) |
0.002 |
|
| Qualification |
5.31 ± 5.80 |
5.01 ± 5.63 |
5.08 ± 5.67 |
0.401 |
|
| Address |
Urban |
518 (24.2) |
1624 (75.8) |
2142(60.8) |
0.408 |
| Rural |
317 (23.0) |
1063 (77.0) |
1380(39.2) |
||
| Weight -kg-(mean ± SD) |
76.84 ± 16.32 |
75.79 ± 17.12 |
76.04 ± 16.94 |
0.122 |
|
| Waist -cm-(mean ± SD) |
98.96 ± 12.4 |
98.3 ± 13.0 |
98.4 ± 12.9 |
0.371 |
|
| BMI |
28.09 ± 5.55 |
27.53 ± 5.62 |
27.6 ± 5.6 |
0.988 |
|
| Waist-hip ratio (mean ± SD) |
0.94 ± 0.06 |
0.94 ± 0.07 |
0.94 ± .07 |
0.030 |
|
| Waist-to-height ratio (mean ± SD) |
0.59 ± 0.07 |
0.59 ± .08 |
0.59 ± .08 |
0.903 |
|
| Type of diabetes |
Type 1 diabetes |
11 (8.7) |
116 (91.3) |
127(3.6) |
< 0.0001 |
| Type 2 diabetes |
824 (24.3) |
2571(75.7) |
3395(96.4) |
||
| Therapy |
Oral * |
744 (26.7) |
2044 (73.3) |
2788 (79.2) |
< 0.0001 |
| Insulin ± oral |
91 (12.4) |
643 (87.6) |
734(20.8) |
< 0.0001 |
|
| Hypertension |
277 (24.5) |
855 (75.5) |
1132(32.1) |
0.471 |
|
| Coronary heart disease |
55 (21.7) |
198 (78.3) |
253 (7.2) |
0.490 |
|
| Cerebrovascular disease |
44 (29.3) |
106 (70.7) |
150(4.3) |
0.116 |
|
| Proteinuria |
48 (25.7) |
139 (74.3) |
187(5.3) |
0.536 |
|
|
|
|||||
|
* Oral including metformin was used for all except in few with high creatinine or type 1 diabetes. |
|||||
|
Mansour Conflict and Health 2008 2:7 doi:10.1186/1752-1505-2-7 |
|||||
